Title : Telmisartan in high-risk cardiovascular patients.

Pub. Date : 2010 Jan 4

PMID : 20102972






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This approach has been adopted in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET), which compared the effects of the ARB telmisartan and the ACE inhibitor ramipril, alone and in combination, on cardiovascular mortality and morbidity in high-risk patients with vascular disease or diabetes mellitus and end-organ damage. Ramipril angiotensin I converting enzyme Homo sapiens